ORKA
Oruka Therapeutics
ORKA
ORKA
21 hedge funds and large institutions have $6.55M invested in Oruka Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
21
Holding in Top 10
–
Calls
$79K
Puts
–
Top Buyers
| 1 | +$1.09M | |
| 2 | +$12.7K | |
| 3 | +$2.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$251 |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$101 |
Top Sellers
| 1 | -$103K | |
| 2 | -$26.7K | |
| 3 | -$26.5K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.13K |